OMNIJECT Trademark

Trademark Overview


On Wednesday, June 5, 2019, a trademark application was filed for OMNIJECT with the United States Patent and Trademark Office. The USPTO has given the OMNIJECT trademark a serial number of 88459971. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2023. This trademark is owned by Alerje, Inc.. The OMNIJECT trademark is filed in the Pharmaceutical Products category with the following description:

Pre-filled autoinjector device sold filled with epinephrine; pre-filled autoinjector device sold filled with insulin; pre-filled autoinjector device sold filled with pharmaceutical preparations, namely, inferons for use in the treatment of cancer and viral infections; pre-filled autoinjector device sold filled with pharmaceutical preparations for use in treating multiple sclerosis; pre-filled autoinjector device sold filled with pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders; pre-filled autoinjector device sold filled with pharmaceutical preparations for treating human immune diseases and conditions; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations for use in stimulating red blood cell production; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations, namely, erythropoiesis stimulating protein
omniject

General Information


Serial Number88459971
Word MarkOMNIJECT
Filing DateWednesday, June 5, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements


Goods and ServicesPre-filled autoinjector device sold filled with epinephrine; pre-filled autoinjector device sold filled with insulin; pre-filled autoinjector device sold filled with pharmaceutical preparations, namely, inferons for use in the treatment of cancer and viral infections; pre-filled autoinjector device sold filled with pharmaceutical preparations for use in treating multiple sclerosis; pre-filled autoinjector device sold filled with pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders; pre-filled autoinjector device sold filled with pharmaceutical preparations for treating human immune diseases and conditions; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations for use in stimulating red blood cell production; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations, namely, erythropoiesis stimulating protein
Pseudo MarkOMNI JECT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlerje, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDetroit, MI 48202

Party NameAlerje, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDetroit, MI 48202

Trademark Events


Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022SOU EXTENSION 5 GRANTED
Thursday, June 16, 2022SOU EXTENSION 5 FILED
Monday, June 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 16, 2022TEAS EXTENSION RECEIVED
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 16, 2021SOU EXTENSION 4 GRANTED
Thursday, December 16, 2021SOU EXTENSION 4 FILED
Thursday, December 16, 2021TEAS EXTENSION RECEIVED
Saturday, June 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021SOU EXTENSION 3 GRANTED
Thursday, June 17, 2021SOU EXTENSION 3 FILED
Thursday, June 17, 2021TEAS EXTENSION RECEIVED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 16, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 16, 2020SOU EXTENSION 2 FILED
Wednesday, December 16, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 1 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, September 17, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 17, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, September 17, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 27, 2019ASSIGNED TO EXAMINER
Wednesday, June 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 8, 2019NEW APPLICATION ENTERED